glp-1 prescriptions growth q1 2025 Thinking about GLP-1s lately? In a new study, we analyzed ~1.4 million adults with sleep apnea from 2017β2025 and found: πΉ 6x increase in new πΉ14x increase in patients taking GLP-1 Receptor Agonist Market Valued
Description
It is vital to recognize the warning signs and act quickly
Makes meal prep easy: Prep once, pack once and bring it with you
While many key sectors have the potential to lose out, others, which appeal to the differing needs of GLP-1 users, could experience a boom
The team saw no differences when it came to risks for high or low birth weight or Cesarean delivery
Neither is common with tirzepatide, but both require evaluation
GLP-1 use was associated with lower rates of papilledema, headache, and visual disturbances, but observational data cannot prove causation
